Answers are grounded in this paper and cite their sources.
Identification and resolution of DRPs through pharmaceutical care resulted in decreased drug use and costs for patients undergoing hemodialysis. Hospitalization rates were significantly lower in the pharmaceutical care group, with a trend toward shorter duration. Provision of pharmaceutical care is associated with tangible benefits on outcomes in ambulatory patients undergoing hemodialysis and should be considered in health care policy decisions.
No takes yet. Share an insight, caveat, or question.
Pai et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: